BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 36241919)

  • 21. Left ventricular function recovery in peripartum cardiomyopathy: a cardiovascular magnetic resonance study by myocardial T1 and T2 mapping.
    Liang YD; Xu YW; Li WH; Wan K; Sun JY; Lin JY; Zhang Q; Zhou XY; Chen YC
    J Cardiovasc Magn Reson; 2020 Jan; 22(1):2. PubMed ID: 31902370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive cardiac magnetic resonance T1, T2, and extracellular volume mapping to define Duchenne cardiomyopathy.
    Sunthankar SD; George-Durrett K; Crum K; Slaughter JC; Kasten J; Raucci FJ; Markham LW; Soslow JH
    J Cardiovasc Magn Reson; 2023 Jul; 25(1):44. PubMed ID: 37517994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Native T1 mapping and extracellular volume fraction for differentiation of myocardial diseases from normal CMR controls in routine clinical practice.
    Thongsongsang R; Songsangjinda T; Tanapibunpon P; Krittayaphong R
    BMC Cardiovasc Disord; 2021 Jun; 21(1):270. PubMed ID: 34082703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Native T1 values identify myocardial changes and stratify disease severity in patients with Duchenne muscular dystrophy.
    Olivieri LJ; Kellman P; McCarter RJ; Cross RR; Hansen MS; Spurney CF
    J Cardiovasc Magn Reson; 2016 Oct; 18(1):72. PubMed ID: 27788681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.
    Wu LM; Chen BH; Yao QY; Ou YR; Wu R; Jiang M; Hu J; An DA; Xu JR
    Int J Cardiovasc Imaging; 2016 Aug; 32(8):1289-97. PubMed ID: 27198892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
    Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracellular volume fraction is more closely associated with altered regional left ventricular velocities than left ventricular ejection fraction in nonischemic cardiomyopathy.
    Collins J; Sommerville C; Magrath P; Spottiswoode B; Freed BH; Benzuly KH; Gordon R; Vidula H; Lee DC; Yancy C; Carr J; Markl M
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular magnetic resonance evidence of myocardial fibrosis and its clinical significance in adolescent and adult patients with Ebstein's anomaly.
    Yang D; Li X; Sun JY; Cheng W; Greiser A; Zhang TJ; Liu H; Wan K; Luo Y; An Q; Chung YC; Han Y; Chen YC
    J Cardiovasc Magn Reson; 2018 Sep; 20(1):69. PubMed ID: 30257686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy.
    Raucci FJ; Xu M; George-Durrett K; Crum K; Slaughter JC; Parra DA; Markham LW; Soslow JH
    J Cardiovasc Magn Reson; 2021 Apr; 23(1):48. PubMed ID: 33910579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffusely Increased Myocardial Extracellular Volume With or Without Focal Late Gadolinium Enhancement: Prevalence and Associations With Left Ventricular Size and Function.
    Lundin M; Sörensson P; Maret E; Jenner J; Abdula G; Nickander J; Themudo R; Caidahl K; Kellman P; Sigfridsson A; Ugander M
    J Thorac Imaging; 2022 Jan; 37(1):17-25. PubMed ID: 32271280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial Native T
    Omori T; Nakamori S; Fujimoto N; Ishida M; Kitagawa K; Ichikawa Y; Kumagai N; Kurita T; Imanaka-Yoshida K; Hiroe M; Sakuma H; Ito M; Dohi K
    JACC Cardiovasc Imaging; 2020 Oct; 13(10):2117-2128. PubMed ID: 32771571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
    JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myocardial extracellular volume fraction measurements with MOLLI 5(3)3 by cardiovascular MRI for the discrimination of healthy volunteers from dilated and hypertrophic cardiomyopathy patients.
    Cui Y; Chen Y; Cao Y; Liu J; Song J; Zhang S; Kong X; Han P; Shi H
    Clin Radiol; 2019 Sep; 74(9):732.e9-732.e16. PubMed ID: 31122714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in hypertension and associated with left ventricular remodeling.
    Wang S; Hu H; Lu M; Sirajuddin A; Li J; An J; Chen X; Yin G; Lan T; Dai L; Zhang Y; Yin X; Song L; Dang A; Kellman P; Arai AE; Zhao S
    Eur Radiol; 2017 Nov; 27(11):4620-4630. PubMed ID: 28439652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac magnetic resonance imaging for the detection of myocardial involvement in granulomatosis with polyangiitis.
    Giollo A; Dumitru RB; Swoboda PP; Plein S; Greenwood JP; Buch MH; Andrews J
    Int J Cardiovasc Imaging; 2021 Mar; 37(3):1053-1062. PubMed ID: 33057879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pattern and prognostic value of cardiac involvement in patients with late-onset pompe disease: a comprehensive cardiovascular magnetic resonance approach.
    Boentert M; Florian A; Dräger B; Young P; Yilmaz A
    J Cardiovasc Magn Reson; 2016 Dec; 18(1):91. PubMed ID: 27931223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis--a clinical study using myocardial T1-mapping and extracellular volume quantification.
    Ntusi NA; Piechnik SK; Francis JM; Ferreira VM; Rai AB; Matthews PM; Robson MD; Moon J; Wordsworth PB; Neubauer S; Karamitsos TD
    J Cardiovasc Magn Reson; 2014 Mar; 16(1):21. PubMed ID: 24593856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging.
    Huang L; Zhao P; Tang D; Zhu T; Han R; Zhan C; Liu W; Zeng H; Tao Q; Xia L
    JACC Cardiovasc Imaging; 2020 Nov; 13(11):2330-2339. PubMed ID: 32763118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitides.
    Greulich S; Mayr A; Kitterer D; Latus J; Henes J; Steubing H; Kaesemann P; Patrascu A; Greiser A; Groeninger S; Braun N; Alscher MD; Sechtem U; Mahrholdt H
    J Cardiovasc Magn Reson; 2017 Jan; 19(1):6. PubMed ID: 28077133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy.
    Soslow JH; Damon SM; Crum K; Lawson MA; Slaughter JC; Xu M; Arai AE; Sawyer DB; Parra DA; Damon BM; Markham LW
    J Cardiovasc Magn Reson; 2016 Jan; 18():5. PubMed ID: 26795569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.